OncoTAb, based in Charlotte, NC, is a cutting-edge biotechnology company that has developed a patented blood test, Agkura Personal Score, to aid in the detection of breast cancer in women with dense breast tissue. Their innovative and non-invasive technology provides a safe and affordable solution for early breast cancer detection, making it easier for patients to access accurate and quality care.
With their specific staining technology, OncoTAb's blood test offers a useful supplemental test alongside mammography for women with dense breast tissue, as it allows for the visualization of strong staining in cases of mammary carcinoma, while benign lesions show absence of staining. Committed to improving breast cancer detection, OncoTAb's groundbreaking approach provides hope and support to women concerned about breast cancer.
Generated from the website